Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Goodman

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|November 1, 1987
Micronutrient assay for cancer prevention clinical trials: serum retinol, retinyl palmitate, alpha-carotene, and beta-carotene with the use of high-performance liquid chromatographyD A Kalman, G E Goodman, G S Omenn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer riskG E Goodman, S Schaffer, D D Bankson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drugD S Alberts, K S Griffith, G E Goodman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 1996
The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancerG E Goodman, M Thornquist, M Kestin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapyG E Goodman, T P Miller, M M Manning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancerG E Goodman, I Hellström, L Brodzinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group studyG E Goodman, J Crowley, R B Livingston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1993
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokersG E Goodman, G S Omenn, M D Thornquist, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinomaN Scholler, N Fu, Y Yang, et al.
Cancer Treatment Reports|September 1, 1984
Plasma kinetics of oral retinol in cancer patientsG E Goodman, D S Alberts, Y M Peng, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|November 1, 1987
Micronutrient assay for cancer prevention clinical trials: serum retinol, retinyl palmitate, alpha-carotene, and beta-carotene with the use of high-performance liquid chromatographyD A Kalman, G E Goodman, G S Omenn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer riskG E Goodman, S Schaffer, D D Bankson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drugD S Alberts, K S Griffith, G E Goodman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 1996
The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancerG E Goodman, M Thornquist, M Kestin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapyG E Goodman, T P Miller, M M Manning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancerG E Goodman, I Hellström, L Brodzinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group studyG E Goodman, J Crowley, R B Livingston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1993
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokersG E Goodman, G S Omenn, M D Thornquist, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinomaN Scholler, N Fu, Y Yang, et al.
Cancer Treatment Reports|September 1, 1984
Plasma kinetics of oral retinol in cancer patientsG E Goodman, D S Alberts, Y M Peng, et al.
Pageof 5